Drug Database
Back to search

Belgium· BE-AMP-SAM154533-00

Livostin 0.5 mg/ml

A levocabastine product containing levocabastine hydrochloride, registered in Belgium by Kenvue Belgium. The same ATC class is registered in 9 of our 19 countries.

ATC S01GX02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLivostin 0.5 mg/mlATCS01GX02REGISTER NO.BE-AMP-SAM154533-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levocabastine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levocabastine is registered in 9 of 19 countries.

Countries holding a registration under ATC S01GX02 (levocabastine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search levocabastine products by name

Levocabastine · ATC S01GX02

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Levocabastine Hydrochloride
Manufacturer
Kenvue Belgium
Country
Belgium (BE)
ATC code
S01GX02
ATC class
Levocabastine
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0251264

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Levocabastine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levocabastine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Levocamed, Livostin
  • Czechia · Livostin
  • Germany · Levocabastin, Levocamed
  • Denmark · Benaliv
  • Spain · Bilina, Reactine
  • Finland · Livostin
  • France · Allergiflash, Levofree
  • Greece · Livostin
  • Iceland · Livostin
  • Italy · Levoreact, Levoreact Oftalmico
  • Luxembourg · Livostin, Nasasinuspray Anti-Allergie
  • Netherlands · Livocab
  • Norway · Livostin
  • Sweden · Livostin
  • Slovakia · Livostin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb6f67ff-35e1-4d4d-82a0-0fcaa038c5ad
GET /v1/drugs/fb6f67ff-35e1-4d4d-82a0-0fcaa038c5ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, suspension",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Livostin 0.5 mg/ml",
  "name_fr": "Livostin 0.5 mg/ml",
  "name_nl": "Livostin 0.5 mg/ml",
  "amp_code": "SAM154533-00",
  "strengths": [
    "0.5400",
    "0.5400",
    "0.5000",
    "0.5000",
    "0.2950",
    "0.1500",
    "5.3800",
    "50.0000",
    "8.6600",
    "1.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Levocabastine Hydrochloride",
    "Levocabastine",
    "Benzalkonium Chloride",
    "Disodium Edetate",
    "Disodium Hydrogen Phosphate",
    "Propylene Glycol",
    "Sodium Dihydrogen Phosphate Anhydrous",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Levocabastine",
  "authorisation_numbers": [
    "BE154533"
  ]
}
API referenceMCP serverPlans

See everything about levocabastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console